A detailed history of China Universal Asset Management Co., Ltd. transactions in Siga Technologies Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 13,727 shares of SIGA stock, worth $86,480. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,727
Previous 8,355 64.3%
Holding current value
$86,480
Previous $63,000 46.03%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$6.74 - $11.97 $36,207 - $64,302
5,372 Added 64.3%
13,727 $92,000
Q2 2024

Jul 19, 2024

SELL
$6.32 - $10.46 $33,527 - $55,490
-5,305 Reduced 38.84%
8,355 $63,000
Q1 2024

Apr 29, 2024

BUY
$4.51 - $8.92 $24,511 - $48,480
5,435 Added 66.08%
13,660 $125,000
Q4 2023

May 21, 2024

SELL
$4.82 - $6.25 $26,196 - $33,968
-5,435 Reduced 39.79%
8,225 $46,000
Q4 2023

Jan 23, 2024

BUY
$4.82 - $6.25 $30,867 - $40,025
6,404 Added 351.67%
8,225 $46,000
Q3 2023

May 21, 2024

BUY
$4.32 - $5.77 $3,831 - $5,117
887 Added 94.97%
1,821 $9,000
Q3 2023

Oct 30, 2023

BUY
$4.32 - $5.77 $3,831 - $5,117
887 Added 94.97%
1,821 $10,000
Q2 2023

May 21, 2024

SELL
$5.0 - $6.31 $275 - $347
-55 Reduced 5.56%
934 $4,000
Q2 2023

Jul 27, 2023

SELL
$5.0 - $6.31 $275 - $347
-55 Reduced 5.56%
934 $5,000
Q1 2023

May 21, 2024

BUY
$5.23 - $8.42 $1,291 - $2,079
247 Added 33.29%
989 $5,000
Q1 2023

Apr 27, 2023

BUY
$5.23 - $8.42 $1,291 - $2,079
247 Added 33.29%
989 $6,000
Q4 2022

May 21, 2024

SELL
$7.29 - $10.14 $94,172 - $130,988
-12,918 Reduced 94.57%
742 $5,000
Q4 2022

Jan 31, 2023

BUY
$7.29 - $10.14 $430 - $598
59 Added 8.64%
742 $5,000
Q3 2022

Oct 21, 2022

BUY
$10.02 - $26.15 $6,843 - $17,860
683 New
683 $7,000

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $460M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.